Abstract:Patent foramen ovale (PFO) represents the most common congenital heart disease (CHD) among subjects from general population having a prevalence ranging between 20 and 30% [ [1] Rigatelli G. Pedon L. Zecchel R. Dell’Avvocata F. Carrozza A. Zennaro M. Mazza A. Zuin M. Russo M. Zanchetta M. Long-term outcomes and complications of Intracardiac echocardiography-assisted patent foramen ovale closure in 1,000 consecutive patients. J. Interv. Cardiol. 2016; 29: 530-538https://doi.org/10.1111/joic.12325 Crossref PubMed Scopus (31) Google Scholar ]. Over the years, several investigations have demonstrated that PFO is implicated in the pathogenesis of different medical conditions [ 2 Rigatelli G. Dell’Avvocata F. Cardaioli P. Giordan M. Braggion G. Aggio S. Chinaglia M. Mandapaka S. Kuruvilla J. Chen J.P. Nanjundappa A. Permanent right-to-left shunt is the key factor in managing patent foramen ovale. J. Am. Coll. Cardiol. 2011; 58: 2257-2261https://doi.org/10.1016/j.jacc.2011.06.06422078434 Crossref PubMed Scopus (55) Google Scholar , 3 Zuin M. Rigatelli G. Rigatelli A. Ronco F. Conte L. Roncon L. Mazza A. Correlations between serum homocysteine levels and RoPE score in patients with patent foramen ovale. Heart Vessel. 2020; 35: 705-711https://doi.org/10.1007/s00380-019-01528-5 Crossref PubMed Scopus (3) Google Scholar , 4 Rigatelli G. Dell’Avvocata F. Ronco F. Cardaioli P. Giordan M. Braggion G. Aggio S. Chinaglia M. Rigatelli G. Chen J.P. Primary transcatheter patent foramen ovale closure is effective in improving migraine in patients with high-risk anatomic and functional characteristics for paradoxical embolism. JACC Cardiovasc. Interv. 2010; 3: 282-287https://doi.org/10.1016/j.jcin.2009.11.019 Crossref PubMed Scopus (36) Google Scholar ] though two main mechanisms: the former represented by the “traditional” paradoxical embolism and the latter due to the Right-to-Left shunt (RLS)-induced left atrial cardiomyopathy [ [5] Rigatelli G. Aggio S. Cardaioli P. Braggion G. Giordan M. Dell’avvocata F. Chinaglia M. Rigatelli G. Roncon L. Chen J.P. Left atrial dysfunction in patients with patent foramen ovale and atrial septal aneurysm: an alternative concurrent mechanism for arterial embolism?. JACC Cardiovasc. Interv. 2008; 2: 655-662https://doi.org/10.1016/j.jcin.2009.05.010 Crossref Scopus (89) Google Scholar , [6] Rigatelli G. Zuin M. Adami A. Aggio S. Lanza D. d’Elia K. Braggion G. Russo M. Mazza A. Roncon L. Left atrial enlargement as a maker of significant high-risk patent foramen ovale. Int. J. Card. Imaging. 2019; 35: 2049-2056https://doi.org/10.1007/s10554-019-01666-x Crossref Scopus (10) Google Scholar ]. Notably, during the latest two decades, due to the widespread diffusion of echocardiography, the identification of either asymptomatic or thrombus straddling a PFO (TSPFO) has drastically increased, especially in patients with some life-threatening disease such as acute pulmonary embolism (PE) or ischemic stroke (IS) [ 7 Zhang M. Tan S. Patel V. Zalta B.A. Shmukler A. Levsky J.M. Jain V.R. Shaban N.M. Haramati L.B. Patent foramen ovale in patients with pulmonary embolism: a prognostic factor on CT pulmonary angiography?. J. Cardiovasc. Comput.Tomogr. 2017; 12: 271-274https://doi.org/10.1016/j.jcct.2017.11.009 Abstract Full Text Full Text PDF PubMed Scopus (5) Google Scholar , 8 Rigatelli G. Zuin M. Not all patent foramen ovales are alike!. Thromb. Res. 2021; 203: 81https://doi.org/10.1016/j.thromres.2021.04.022 Abstract Full Text Full Text PDF PubMed Scopus (1) Google Scholar , 9 Consoli D. Paciaroni M. Aguggia M. Melis M. Malferrari G. Vidale S. Cerrato P. Sacco S. Gandolfo C. Bovi P. Serrati C. Del Sette M. Cavallini A. Diomedi M. Postorino P. Ricci S. Prevalence of patentforamen ovale in ischemic stroke in Italy: the SISIFO study. Neurol. Sci. 2014; 35: 867-873https://doi.org/10.1007/s10072-013-1615-2 Crossref PubMed Scopus (6) Google Scholar ]. As a matter of a fact, in current daily clinical practice, TSPFO is generally recognized as a source of acute IS. In this number of the journal, Shah and colleagues performed an interesting analysis based on patient-level data, investigating whether acute myocardial infarction (AMI) or IS in patients having TSPFO upon the admission, may be associated with a higher in-hospital mortality [ [10] Shah P. Jimenez-Ruiz A. Gibson A. Vargas-González J.C. Bres-Bullrich M. Bagur R. Sposato L.A. Association between acute myocardial infarction and death in 386 patients with a thrombus straddling a patent foramen ovale. Int. J. Cardiol. 2021; S0167-5273 (Epub ahead of print): 01101-01103https://doi.org/10.1016/j.ijcard.2021.07.007 Abstract Full Text Full Text PDF Scopus (1) Google Scholar ]. For this purpose, the authors performed a systematic search, without language restrictions, describing case-reports or series of adult patients with TSPFO between 1950 to October 30, 2020.

Characteristics of patients diagnosed for cardiological cause of ischemic neurological events and pre-screened with a transcranial doppler examination

Embolic implications of combined risk factors in patients with patent foramen ovale (the CARPE criteria): consideration for primary prevention closure?

Increased Blood Residence Time As Markers of High-Risk Patent Foramen Ovale.

Morphological Features of Patent Foramen Ovale Compared Between Older and Young Patients With Cryptogenic Ischemic Stroke

Atrial septal aneurysm contribution to the risk of cryptogenic stroke in patients with patent foramen ovale: A brief updated systematic review and meta-analysis.

Assessment of the Characteristics of Patent Foramen Ovale Associated with Cryptogenic Stroke

Resolution of migraine by transcatheter patent foramen ovale closure with Premere Occlusion System in a preliminary series of patients with previous cerebral ischemia.

Management of Patients with Patent Foramen Ovale and Cryptogenic Stroke: a Collaborative, Multidisciplinary, Position Paper.

Migraine-patent foramen ovale connection: role of prominent eustachian valve and large Chiari network in migrainous patients.

PFO-spectrum disorder: two different cerebrovascular diseases in patients with PFO as detected by AI brain imaging software

PATENT FORAMEN OVALE IN ELDERLY PEOPLE

Patent foramen ovale closure in over-60-years old patients with diastolic dysfunction

Closing Patent Foramen Ovale in Cryptogenic Stroke: the Underscored Importance of Other Interatrial Shunt Variants

Patent foramen ovale in the elderly: what to do?

Characteristics of Patent Foramen Ovale: Analysis from a Single Center

The association of different right atrium anatomical-functional characteristics correlates with the risk of paradoxical stroke: an intracardiac echocardiographic study.

ICE-guided Patent Foramen Ovale (PFO) Closure with Lastest-Generation Devices: the Ideal Strategy for PFO-related Migraine?

Patent Foramen Ovale with Paradoxical Embolism: Mid‐Term Results of Transcatheter Closure in 256 Patients

Thrombus Straddling a Patent Foramen Ovale: Also a Myocardial Infarction Matter?

Left Atrial Dysfunction in Patients with Patent Foramen Ovale and Atrial Septal Aneurysm Scheduled for Transcathter Closure May Play a Role in Aura Genesis

Transcatheter Patent Foramen Ovale Closure is Effective in Reducing Migraine Independently from Specific Interatrial Septum Anatomy and Closure Devices Design.